Press Releases - 2023-11-03

Date	Title	Company
03-Nov-2023	Hudson Therapeutics, Inc. Appoints Janice Marie McCourt as co-Chief Executive Officer and Board Member	Businesswire
03-Nov-2023	Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)	Businesswire
03-Nov-2023	Cimeio Therapeutics Announces Poster Presentations at ASH 2023	Businesswire
03-Nov-2023	Boveda® Inc. Acquires FreshStor Elevating Cannabis Storage	Businesswire
03-Nov-2023	InGeneron Announces Encouraging Results from Emory University’s 480-Patient Phase III Knee Osteoarthritis Trial	Businesswire
03-Nov-2023	China Pharmaceutical Competitive Landscape and Drugs Pipeline Analysis Report 2023: Business Overview of 330 Companies, 1500 Drugs in Trials, & 200 Commercially Approved Drugs - ResearchAndMarkets.com	Businesswire
03-Nov-2023	China Bispecific Antibodies Market and Clinical Pipeline Insight Report 2023: A $5 Billion Opportunity by 2028, 250 Pipeline Bispecific Antibodies, 50 Bispecific Antibodies Available for License - ResearchAndMarkets.com	Businesswire
03-Nov-2023	Genomic Vision Requests Receivership Proceedings	Businesswire
03-Nov-2023	Ankyra Therapeutics Announces Promising Preclinical Data on ANK-101, a Novel Anchored Immune Medicine, in Combination with Cytotoxic Chemotherapy in Head and Neck Cancer Model	Businesswire
03-Nov-2023	Hearables in Medical Devices Thematic Intelligence Research Report 2023: More Than Just Headphones, They're Your Personal Digital Assistants - ResearchAndMarkets.com	Businesswire
03-Nov-2023	Clinical Consensus on Kerecis Fish-Skin Grafts to be Presented at the SAWC Wound Conference	Businesswire
03-Nov-2023	Global mRNA Vaccine Market Research Report 2023: On-going Clinical Trials, Drug Pipeline, Mergers & Acquisitions, & Product Launches - ResearchAndMarkets.com	Businesswire
03-Nov-2023	AbCellera Presents New Data on Two T-Cell Engager Programs at SITC 2023	Businesswire
03-Nov-2023	TriSalus Life Sciences Presents Data for SD-101 Delivered by TriSalus Infusion System for Pancreatic Adenocarcinoma at the Society for Immunotherapy of Cancer (SITC) Annual Meeting	Businesswire
03-Nov-2023	ProfoundBio Presents Promising Data on ADC Programs, Including Early Clinical Results of Rinatabart Sesutecan in Ovarian and Endometrial Cancers, at SITC 2023	Businesswire
03-Nov-2023	Seagen Highlights First Solid Tumor Data for an ADCETRIS® (brentuximab vedotin) Immunotherapy Combination and Preclinical Data for Novel CD30-Directed Antibody-Drug Conjugate at Society for Immunotherapy of Cancer (SITC) Annual Meeting	Businesswire
03-Nov-2023	Secarna Pharmaceuticals presents data at SITC demonstrating the potential of antisense oligonucleotides in targeting NRP1	Secarna Pharmaceuticals GmbH & Co. KG
03-Nov-2023	Disposable Negative Pressure Wound Therapy Devices Industry Anticipated to Exceed US$461.3 Million in 2028 \| FMI	MARKITWIRED
03-Nov-2023	Pernicious Anemia Testing Market Size, Share, Trends, Demand, Growth and Competitive Analysis	The Wire Times
03-Nov-2023	Dry Powder Inhaler Industry Anticipated to Hit US$ 29.6 Billion by 2031, With 4.6% of CAGR \| FMI	MARKITWIRED